BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19

• 

  Events

  Register: Shifting Risk | Biopharma in an Age of Deregulation

  BioSpace sits down with former FDA Chief Information Officer Vid Desai to discuss the potential advantages and pitfalls of deregulation stemming from one of President Donald Trump’s first executive orders. We will uncover what this shift means for drugmakers, compliance and patient safety.

  September 17, 2025
• 

  EvolveImmune Therapeutics, Inc.
• 

  Bexorg
• 

  SCA Pharmaceuticals
• 

  Amneal Pharmaceuticals
• 

  Clinilabs, Inc.
• 

  Cresilon
• 

  MindImmune Therapeutics
• 

  PathMaker Neurosystems Inc.
• 

  Larimar Therapeutics